ID   CL89-17872
AC   CVCL_WY84
DR   Wikidata; Q93454290
RX   PubMed=8986805;
RX   PubMed=11717438;
CC   Sequence variation: Gene fusion; HGNC; HGNC:9343; PRCC + HGNC; HGNC:11752; TFE3; Name(s)=PRCC-TFE3 (PubMed=8986805).
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C27891; Renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions
DI   ORDO; Orphanet_319308; MiT family translocation renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 19-12-24; Version: 9
//
RX   PubMed=8986805; DOI=10.1073/pnas.93.26.15294; PMCID=PMC26398;
RA   Weterman M.A.J., Wilbrink M., van Kessel A.G.;
RT   "Fusion of the transcription factor TFE3 gene to a novel gene, PRCC,
RT   in t(X;1)(p11;q21)-positive papillary renal cell carcinomas.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:15294-15298(1996).
//
RX   PubMed=11717438; DOI=10.1073/pnas.241304198; PMCID=PMC61123;
RA   Weterman M.A.J., van Groningen J.J.M., Tertoolen L.G.J.,
RA   van Kessel A.G.;
RT   "Impairment of MAD2B-PRCC interaction in mitotic checkpoint defective
RT   t(X;1)-positive renal cell carcinomas.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:13808-13813(2001).
//